BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 28576945)

  • 1. The Role of CtBP1 in Oncogenic Processes and Its Potential as a Therapeutic Target.
    Blevins MA; Huang M; Zhao R
    Mol Cancer Ther; 2017 Jun; 16(6):981-990. PubMed ID: 28576945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional corepressor CtBP: a foe of multiple tumor suppressors.
    Chinnadurai G
    Cancer Res; 2009 Feb; 69(3):731-4. PubMed ID: 19155295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors.
    Dcona MM; Morris BL; Ellis KC; Grossman SR
    Cancer Biol Ther; 2017 Jun; 18(6):379-391. PubMed ID: 28532298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and characterization of a new potent inhibitor targeting CtBP1/BARS in melanoma cells.
    Filograna A; De Tito S; Monte ML; Oliva R; Bruzzese F; Roca MS; Zannetti A; Greco A; Spano D; Ayala I; Liberti A; Petraccone L; Dathan N; Catara G; Schembri L; Colanzi A; Budillon A; Beccari AR; Del Vecchio P; Luini A; Corda D; Valente C
    J Exp Clin Cancer Res; 2024 May; 43(1):137. PubMed ID: 38711119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Active-Site Tryptophan, the Target of Antineoplastic C-Terminal Binding Protein Inhibitors, Mediates Inhibitor Disruption of CtBP Oligomerization and Transcription Coregulatory Activities.
    Dcona MM; Damle PK; Zarate-Perez F; Morris BL; Nawaz Z; Dennis MJ; Deng X; Korwar S; Singh SJ; Ellis KC; Royer WE; Bandyopadhyay D; Escalante C; Grossman SR
    Mol Pharmacol; 2019 Jul; 96(1):99-108. PubMed ID: 31036695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of transcriptional corepressor CtBP1 in prostate cancer progression.
    Wang R; Asangani IA; Chakravarthi BV; Ateeq B; Lonigro RJ; Cao Q; Mani RS; Camacho DF; McGregor N; Schumann TE; Jing X; Menawat R; Tomlins SA; Zheng H; Otte AP; Mehra R; Siddiqui J; Dhanasekaran SM; Nyati MK; Pienta KJ; Palanisamy N; Kunju LP; Rubin MA; Chinnaiyan AM; Varambally S
    Neoplasia; 2012 Oct; 14(10):905-14. PubMed ID: 23097625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation by C-terminal binding proteins.
    Chinnadurai G
    Int J Biochem Cell Biol; 2007; 39(9):1593-607. PubMed ID: 17336131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small Molecule, NSC95397, Inhibits the CtBP1-Protein Partner Interaction and CtBP1-Mediated Transcriptional Repression.
    Blevins MA; Kouznetsova J; Krueger AB; King R; Griner LM; Hu X; Southall N; Marugan JJ; Zhang Q; Ferrer M; Zhao R
    J Biomol Screen; 2015 Jun; 20(5):663-72. PubMed ID: 25477201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CtBP family protein isoforms in breast cancer and their role in chemoresistance.
    Birts CN; Harding R; Soosaipillai G; Halder T; Azim-Araghi A; Darley M; Cutress RI; Bateman AC; Blaydes JP
    Biol Cell; 2010 Jan; 103(1):1-19. PubMed ID: 20964627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel corepressor, BCoR-L1, represses transcription through an interaction with CtBP.
    Pagan JK; Arnold J; Hanchard KJ; Kumar R; Bruno T; Jones MJ; Richard DJ; Forrest A; Spurdle A; Verdin E; Crossley M; Fanciulli M; Chenevix-Trench G; Young DB; Khanna KK
    J Biol Chem; 2007 May; 282(20):15248-57. PubMed ID: 17379597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CtBP1 transactivates RAD51 and confers cisplatin resistance to breast cancer cells.
    Deng Y; Guo W; Xu N; Li F; Li J
    Mol Carcinog; 2020 May; 59(5):512-519. PubMed ID: 32124501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA485-3p negatively regulates the transcriptional co-repressor
    Du K; Zhang X; Lou Z; Guo P; Zhang F; Wang B; Chen L; Zhang C
    Int J Biol Sci; 2018; 14(11):1445-1456. PubMed ID: 30262996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CtBP1-p300-FOXO3a transcriptional complex represses the expression of the apoptotic regulators Bax and Bim in human osteosarcoma cells.
    Li C; Xiao XQ; Qian YH; Zhou ZY
    J Cell Physiol; 2019 Dec; 234(12):22365-22377. PubMed ID: 31074088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-dependent corepressor LCoR is an attenuator of progesterone-regulated gene expression.
    Palijan A; Fernandes I; Verway M; Kourelis M; Bastien Y; Tavera-Mendoza LE; Sacheli A; Bourdeau V; Mader S; White JH
    J Biol Chem; 2009 Oct; 284(44):30275-87. PubMed ID: 19744932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer.
    Raza U; Saatci Ö; Uhlmann S; Ansari SA; Eyüpoğlu E; Yurdusev E; Mutlu M; Ersan PG; Altundağ MK; Zhang JD; Doğan HT; Güler G; Şahin Ö
    Oncotarget; 2016 Aug; 7(31):49859-49877. PubMed ID: 27409664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The transrepression and transactivation roles of CtBPs in the pathogenesis of different diseases.
    Chen Z
    J Mol Med (Berl); 2021 Oct; 99(10):1335-1347. PubMed ID: 34196767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the PLDLS-binding cleft region of CtBP1 in recruitment of core and auxiliary components of the corepressor complex.
    Kuppuswamy M; Vijayalingam S; Zhao LJ; Zhou Y; Subramanian T; Ryerse J; Chinnadurai G
    Mol Cell Biol; 2008 Jan; 28(1):269-81. PubMed ID: 17967884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-terminal binding proteins: central players in development and disease.
    Stankiewicz TR; Gray JJ; Winter AN; Linseman DA
    Biomol Concepts; 2014 Dec; 5(6):489-511. PubMed ID: 25429601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pathogenic CtBP1 missense mutation causes altered cofactor binding and transcriptional activity.
    Beck DB; Subramanian T; Vijayalingam S; Ezekiel UR; Donkervoort S; Yang ML; Dubbs HA; Ortiz-Gonzalez XR; Lakhani S; Segal D; Au M; Graham JM; Verma S; Waggoner D; Shinawi M; Bönnemann CG; Chung WK; Chinnadurai G
    Neurogenetics; 2019 Aug; 20(3):129-143. PubMed ID: 31041561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic targeting of C-terminal binding protein in human cancer.
    Straza MW; Paliwal S; Kovi RC; Rajeshkumar B; Trenh P; Parker D; Whalen GF; Lyle S; Schiffer CA; Grossman SR
    Cell Cycle; 2010 Sep; 9(18):3740-50. PubMed ID: 20930544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.